Authors

Latest:

Earlier CAR T Use in Multiple Myeloma: Game Changer or Boutique Medicine?

Krina K. Patel, MD, MSc, discusses her thoughts on moving CAR T-cell therapy up in the lines of treatment for patients with multiple myeloma.

Kevin Zarrabi, MD

Latest:

Dr Zarrabi on Questions Regarding the Use of Triplet Therapy in Prostate Cancer

Kevin Kayvan Zarrabi, MD, MS, FACP, discusses remaining questions regarding treatment consisting of triplet therapy in patients with metastatic castration-sensitive prostate cancer.

Susan Faye Dent, MD

Latest:

Dr. Dent on the Clinical Implications of the MONALEESA-2 Trial in HR+/HER2- Breast Cancer

Susan Faye Dent, MD, discusses the clinical implications of the phase 3 MONALEESA-2 trial in hormone receptor–positive, HER2-negative breast cancer.

Mary B. Beasley, MD

Latest:

Harnessing the Ability to Target NRG1 Fusions in NSCLC, Pancreatic Cancer

Mary B. Beasley, MD, discusses the prevalence of NRG1 fusions in non–small cell lung cancer and pancreatic cancer.

Martine Extermann, MD, PhD

Latest:

Dr. Extermann on the Significance of Novel Treatment Options in HER2+ Breast Cancer

Martine Extermann, MD, PhD, discusses the significance of novel treatment options in HER2-positive breast cancer.

Flavio G. Rocha, MD, FACS, FSSO, Oregon Health & Science University

Latest:

Novel Targeted Therapies Under Investigation in Biliary Tract Cancers

Comprehensive insight on novel targeted agents under investigation in the setting of biliary tract cancers.

John L. Hays, MD, PhD

Latest:

Dr Hays on Unmet Needs in CRC

John L. Hays, MD, PhD, discusses unmet needs for patients with colorectal cancer and future directions for research in this disease.

Shravan Kandula, MD

Latest:

Clinical Scenario: Metastatic EBV-Positive NPC

The panel provides clinical insights on the treatment of a patient with metastatic EBV-positive nasopharyngeal carcinoma.

Samuel Cytryn, MD

Latest:

Immunotherapy's Effect on the Upper GI Cancer Treatment Paradigm

Samuel Cytryn, MD, and David B. Zhen, MD, discuss how immunotherapy has affected the treatment paradigm for upper gastrointestinal cancers.

Wesley J. Talcott, MD, MBA

Latest:

Dr Talcott on Treatment De-Escalation in Elderly Patients With Breast Cancer

Wesley J. Talcott, MD, MBA, discusses the importance of de-escalating therapy in patients with breast cancer, highlighting use of personalized treatment approaches.

Lakshmi Rajdev, MD, MS

Latest:

Dr. Rajdev on Detecting HER2 Positivity in GI Cancer

Lakshmi Rajdev, MD, MS, discusses detecting HER2 positivity in patients with gastrointestinal cancers.

Tarita O. Thomas, MD, PhD

Latest:

Closing Thoughts and Key Takeaways on Small Cell Lung Cancer

In a forward-looking discussion, Ticiana Leal, MD; Anne Chiang, MD, PhD; Afshin Dowlati, MD; and Tarita O. Thomas, MD, PhD, offer their concluding insights on the evolving landscape of clinical trials and the future directions of small cell lung cancer (SCLC) treatment, highlighting promising areas of research and potential breakthroughs that may shape the management of this challenging disease in the years to come.

Viktor Grünwald, MD, PhD

Latest:

Dr Grünwald on Examining Progression Patterns for Lenvatinib Plus Pembrolizumab in Advanced RCC

Viktor Grünwald, MD, PhD, on patterns of progression and subsequent therapy for patients with advanced RCC treated during the phase 3 CLEAR trial.

Michal F. Segal, RN

Latest:

Closing Thoughts on Evolving Antibody-Drug Conjugate Landscape

The expert panel concludes the program with key takeaways and closing thoughts on the evolving antibody-drug conjugate space.

Cristina Lopez-Peñalver, MD

Latest:

Reviewing Best Practices in the Surgical Management of Breast Cancer: Post-Surgery Outcomes in Stage IV Disease

In this final episode of OncChats: Reviewing Best Practices in the Surgical Management of Breast Cancer, Gladys Giron, MD, FACS, and Cristina Lopez-Peñalver, MD, shed light on clinical outcomes following surgery of the primary tumor in patients with stage IV breast cancer.

Nikhil Wagle, MD

Latest:

Direct Partnership With Patients May Accelerate Cancer Research and Precision Oncology

During the past several decades, cancer research has produced revolutionary discoveries leading to dramatic results for many patients.

Lilyana Angelov, MD

Latest:

Clinical Updates for the Management of Lung Cancer Brain Metastases

As improved cancer therapies are helping patients live longer, the safe and effective management of lung cancer brain metastases is coming to the fore.

Michel Ducreux, MD, PhD

Latest:

Dr Ducreux on the Potential Use of Liver Transplantation Plus Chemo for CRC Liver Metastases

Michel Ducreux, MD, PhD, discusses the rationale for the TRANSMET trial in patients with CRC liver metastases, highlighting the significance of data from the trial.

Yayi Zhao

Latest:

Zhao on Existing Medical Conditions and Cancer Clinical Trial Enrollment

Yayi Zhao, discusses how the prevalence of existing medical conditions and clinical factors may vary by race and effect eligibility for enrollment in clinical trials in patients with cancer.

Wendy Osborne, MD

Latest:

Comparing the UK & US Approaches to First-Line Treatment in Hodgkin Lymphoma